Treatment of TMJ Osteoarthritis
Initial Conservative Management
- The American College of Rheumatology recommends starting with jaw exercises and stretching, which provide approximately 1.5 times the minimally important difference in pain reduction, and should be initiated immediately 2
- Manual trigger point therapy is strongly recommended as it provides nearly twice the minimally important difference in pain reduction 2
- Scheduled NSAIDs, particularly diclofenac sodium, are conditionally recommended for pain and inflammation control, though trials should be brief due to potential adverse effects 3, 1
- Patient education about avoiding aggravating activities, maintaining a soft diet, and applying heat/cold therapy reduces pain and inflammation 2
- Cognitive behavioral therapy with or without biofeedback provides substantial pain reduction when psychological factors contribute 2
Second-Line Conservative Options
- Occlusal splints/mouthguards may be beneficial specifically for patients with documented bruxism and orofacial symptoms, though they are conditionally recommended against as a general intervention due to limited evidence 1, 2
- Physical therapy and jaw mobilization may improve range of motion and reduce stiffness 4, 2
- Acupuncture shows moderate evidence of effectiveness for TMJ pain relief 2
- Intra-articular lavage (arthrocentesis without steroids) may provide symptomatic relief in both growing and skeletally mature patients with refractory symptoms 1, 4
Pharmacological Escalation
- Neuromodulatory medications, such as amitriptyline and gabapentin, can be considered for chronic refractory pain 2
- Strongly avoid combining NSAIDs with opioids due to increased risks without clear additional benefits 2
Intra-Articular Glucocorticoid Injections
- Conditionally recommended for arthritis-induced refractory and symptomatic TMJ dysfunction in skeletally mature patients 1, 4
- Not recommended as first-line management in skeletally immature patients due to unique TMJ-specific adverse events including potential growth disturbances 1, 4
- No preferred steroid type has been identified 3
- Oral glucocorticoids are conditionally recommended against as part of initial therapy 3, 4
Advanced Therapy for Inflammatory TMJ Arthritis
- Conventional synthetic DMARDs are strongly recommended, with methotrexate as the preferred agent and leflunomide as an alternative 3, 1, 2
- Biologic DMARDs, particularly TNF inhibitors, are conditionally recommended for inadequate response to NSAIDs, intra-articular glucocorticoids, and at least one conventional synthetic DMARD 3, 1, 2
Surgical Interventions
- Arthroscopy may be considered for internal joint assessment and treatment 2
- Skeletal surgery may be indicated in patients with dentofacial deformities and controlled TMJ arthritis 1
- Joint replacement may be considered in selected patients with joint destruction or ankylosis 2
- Strongly avoid discectomy (surgical disc removal) due to potential harms and lack of evidence 2
Critical Pitfalls to Avoid
- Never proceed to invasive procedures before exhausting conservative options for at least 3-6 months 2
- Do not perform repeated glucocorticoid injections in skeletally immature patients due to risk of growth disturbances 1, 4, 2
- Avoid irreversible procedures like permanent dental alterations or discectomy without clear structural indication 2
- Do not rely solely on occlusal splints despite their widespread use, as evidence for effectiveness is limited except in documented bruxism 2
- Never combine NSAIDs with opioids due to increased harm without additional benefit 2
Monitoring and Prognostic Considerations
- Contrast-enhanced MRI is the best method to detect active TMJ arthritis 1
- TMJ is considered a high-risk joint due to its major impact on activities of daily living, warranting early and potentially aggressive treatment 1
- Treatment is recommended regardless of clinical symptoms due to the potentially destructive nature and impact on oral health-related quality of life 1
- Consider poor prognostic features, such as erosive disease, elevated inflammation markers, and delay in diagnosis, to guide treatment intensity 3, 1